[1]蒋海兵.血清ProGRP和NSE检测在小细胞肺癌诊断和放化疗监测中的价值[J].现代检验医学杂志,2018,33(06):153-156.[doi:10.3969/j.issn.1671-7414.2018.06.040]
　JIANG Hai-bing.Value of Serum ProGRP and NSE Detection in the Diagnosis of Small Cell Lung Cancer and the Monitoring of Radiotherapy and Chemotherapy[J].Journal of Modern Laboratory Medicine,2018,33(06):153-156.[doi:10.3969/j.issn.1671-7414.2018.06.040]
点击复制

血清ProGRP和NSE检测在小细胞肺癌诊断和放化疗监测中的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
153-156
栏目:
检验与临床
出版日期:
2018-12-24

文章信息/Info

Title:
Value of Serum ProGRP and NSE Detection in the Diagnosis of Small Cell Lung Cancer and the Monitoring of Radiotherapy and Chemotherapy
文章编号:
1671-7414(2018)06-153-04
作者:
蒋海兵
厦门医学院附属第二医院检验科,福建厦门361021
Author(s):
JIANG Hai-bing
Department of Clinical Laboratory, the Second Affiliated Hospital of Xiamen Medical College,Fujian Xiamen 361021,China
关键词:
胃泌素释放肽前体;  神经元特异性烯醇化酶;  小细胞肺癌
分类号:
R734.2; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.06.040
文献标志码:
A
摘要:
目的 探讨血清胃泌素释放肽前体(ProGRP)和神经元特异性烯醇化酶(NSE)在小细胞肺癌(SCLC)临床诊断和化放疗监测中的意义。方法 分别对2015年9月～2018年1月期间,厦门市第二医院就诊的84例SCLC患者、77例非小细胞肺癌(NSCLC)患者、80例肺良性疾病患者及80例健康体检者的血清ProGRP和NSE进行化学发光法检测; 同时监测84例SCLC患者连续3个周期放化疗后的血清ProGRP和NSE水平变化,采用SPSS17.0进行统计学分析。结果 SCLC组患者的血清ProGRP和NSE浓度显著高于其它组(P<0.05)。血清ProGRP单独检测诊断SCLC,LD-SCLC和ED-SCLC的敏感度和特异度均优于血清NSE,两者联合诊断的敏感度最高。连续3个周期的放化疗后,在治疗有效组中SCLC患者血清ProGRP和NSE水平均有显著下降(P<0.05); 治疗稳定组患者无明显变化(P>0.05); 治疗无效组患者血清NSE无明显增高(P>0.05),但血清ProGRP治疗后较治疗前有显著增高(P<0.05)。结论 血清ProGRP和NSE均可用于SCLC患者的诊断和放化疗的疗效监测,其中两者联合检测可有效提高SCLC患者的诊断率,血清ProGRP更能反映患者放化疗的疗效。
Abstract:
Objective To study the serum levels of pro-gastrin-releasing peptide(ProGRP)and neuron specific enolase(NSE)for the clinical diagnosis and therapy monitoring of small cell lung cancer(SCLC).Methods Patients and healthy people of the Second Affiliated Hospitalof Xiamen Medical College form September 2015 to January 2018 were enrolled,including 84 patients with SCLC,77 patients with non-small cell lung cancer(NSCLC),80 patients with benign pulmonary diseases and 80 healthy people.The serumlevels of ProGRP and NSE were measured by Chemiluminescence,and monitored thelevels of ProGRP and NSE in SCLC patients after 3 consecutive cycles of radiochemization.SPSS17.0 was used to analyse the results.Results The serum levels of ProGRP and NSE in SCLC group were significantly higher than those in other groups(P<0.05).The sensitivity and specificity of serum ProGRP in the diagnosis of SCLC,LD-SCLC and ED-SCLC were better than that of serum NSE, and the sensitivity of combined diagnosis was the highest.After three cycles of treatment,the serum ProGRP and NSE levels were significantly decreased in the effective treatment group(P<0.05),there were no significantchanges in the treatment stable group(P>0.05),in the ineffective treatment group,the serum NSE had no significant increase(P>0.05),but the serumProGRP was significantly higher than that before treatment(P<0.05).Conclusion Serum ProGRP and NSE can be used in the diagnosis of SCLC patients and monitoring the efficacy of radiotherapy and chemotherapy,the combined detection of both can effectively improve the diagnosis rate of SCLCpatients,and serum ProGRP is more effective in responding to the efficacy of chemoradiotherapy.

参考文献/References:

[1] 于 溪,张彬彬,杨碧洁,等.乳酸脱氢酶和神经元特异性烯醇化酶水平与广泛期小细胞肺癌预后的关系[J].中国医科大学学报,2017,46(5):425-428.
Yu X,Zhang BB,Yang BJ,et al.Correlation of lactate dehydrogenaseand neuron-specific enolase with prognosis of extensive small cell lung cancer[J].J Chin Med Univ,2017,46(5):425-428.
[2] 沈 迪,韩彬彬,陈 锋,等.血清胃泌素释放肽前体用于诊断小细胞肺癌的临界参考值建立及诊断价值评估[J].中华医学杂志,2017,97(34):2657-2662.
Shen D,Han BB,Chen F,et al.Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer andevaluation on the clinical diagnosis efficiency[J].Natl Med J China,2017,97(34):2657-2662.
[3] Li XX,Zhou SL,Wang HJ,et al.The clinical value of tissue polypeptidespecific antigen,neuron-specific enolase,carcinoembryonic antigen and CA125 level in small cell lung cancer[J].Chin J Lab Med,2008,31(9):1011-1015.
[4] 隋 鑫,谭 平.ProGRP,NSE,CEA对小细胞肺癌诊治的临床意义[J].中国实验诊断学,2017,21(7):1161-1162.
Sui X,Tan P,Clinical significance of ProGRP,NSE and CEA in diagnosis and treatment of small cell lung cancer[J].Chin J Lab Diagn,2017,21(7):1161-1162.
[5] 杨 兴,孙桂荣,丛培珊,等.胃泌素释放肽前体对小细胞肺癌的诊断价值[J].中华检验医学杂志,2012,35(8):736-741.
Yang X,Sun GR,Cong PS,et al.The significance of pro-gastrin-releasing peptide for small cell lung cance diagnosis[J].Chin J Lab Med,2012,35(8):736-741.
[6] 支修益.肿瘤标志物ProGRP助力小细胞肺癌的临床决策[J].中国肿瘤外科杂志,2014,6(1):42-43.
Zhi XY.Clinical decision of tumor marker ProGRP assisting small cell lung cance[J].Chin J Surg Onco,2014,6(1):42-43.
[7] Stovold R,Meredith SL,Bryant JL,et al.Neuroendocrine and epithelial phenotypes in small-cell lung cancer:implications for metastasis and survival in patients[J].Br J Cancer,2013,108(8):1704-1711.
[8] Lee JE,Lee JH,Hong M,et al.Instability of plasma and serum progastrin-releasing peptide during repeated freezing and thawing[J].Osong Public Health Res Perspect,2016,7(6):351-355.
[9] 王 敏,吕 萌,史小芹,等.胃泌素释放肽前体和神经元特异性烯醇化酶对小细胞肺癌诊断的差异及联合检测[J].中华检验医学杂志,2013,36(11):1008-1012.
Wang M,L(¨overu)M,Shi XQ,et al.Value of pro-GRP and NSE in the diagnosis of small-cell lung cancer difference and combination detection[J].Chin J Lab Med,2013,36(11):1008-1012.
[10] Ono A,Naito T,Ito I,et al.Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels,and the radiologieal response to treatment and survival of patients with small-cell lung cancer[J].Lung Cancer,2012,76(3):439-444.
[11] 梁健伟,张 颖,李万莎,等.胃泌素释放肽前体对小细胞肺癌诊断的临床意义[J]. 国际检验医学杂志,2017,38(2):174-176.
Liang JW,Zhang Y,Li WS,et al.The diagnostic value of ProGRP for smallcell lung cancer[J].Int J Lab Med,2017,38(2):174-176.
[12] Molina R,Holdenrieder S,Auge JM,et al.Diagnostic relevance of circulating biomarkers in patients with lung cancer[J].Cancer Biomark,2010,6(3/4):163-178.
[13] 秦家濂,吴金燕.胃泌素释放肽前体作为小细胞肺癌标记物的临床意义探讨[J].热带医学杂志,2012,12(7):861-863.
Qin JL,Wu JY.Clinical significance of serum pro-gastrin releasing peptide(Pro-GRP)detection in small cell lung cancer[J].J Trop Med,2012,12(7):861-863.
[14] Petrovic M,Bukumiric Z,Zdravkovic V,et al.The prognostic significance of the circulating neuroendocrine markers chromogranin A,pro-gastrin-releasing peptide,and neuron-specific enolase in patients with small-cell lung cancer[J].J Med Oncol,2014,31(2):823.

相似文献/References:

[1]翟海军,朱 晶.NSE在糖尿病周围神经病变中的应用价值[J].现代检验医学杂志,2015,30(04):161.[doi:10.3969/j.issn.1671-7414.2015.04.050]
　ZHAI Hai-jun,ZHU Jing.Application of NSE in Diabetic Peripheral Neuropathy[J].Journal of Modern Laboratory Medicine,2015,30(06):161.[doi:10.3969/j.issn.1671-7414.2015.04.050]
[2]赵车冬,闫玉珠,吴文婧,等.血清CEA,CYFRA21-1,NSE水平在肺癌诊断与分型中的应用价值[J].现代检验医学杂志,2016,31(06):59.[doi:10.3969/j.issn.1671-7414.2016.06.016]
　ZHAO Che-dong,YAN Yu-zhu,WU Wen-jing,et al.Application Value of Serum CEA,CYFRA21-1 and NSE Levels in the Diagnosis and Typing of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):59.[doi:10.3969/j.issn.1671-7414.2016.06.016]
[3]季红兵,唐芹芳,陈思聪,等.血清肿瘤标志物HE4对肺癌的诊断价值[J].现代检验医学杂志,2017,32(02):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]
　JI Hong-bin,TANG Qin-fang,CHEN Si-cong,et al.Application of Serum HE4 in the Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2017,32(06):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]
[4]薛万华,杨 婷.创伤性颅脑损伤患者血液NSE,hsCRP水平和NLR指标与疾病程度相关价值研究[J].现代检验医学杂志,2018,33(05):35.[doi:10.3969/j.issn.1671-7414.2018.05.010]
　XUE Wan-hua,YANG Ting.Study on the Correlation of Disease Severity with the Serum NSE,sCRP Level and NLR in TBI Patients[J].Journal of Modern Laboratory Medicine,2018,33(06):35.[doi:10.3969/j.issn.1671-7414.2018.05.010]
[5]张利祥,潘 静,赵 洁,等.痰液基细胞学检查与血清CYFRA21-1,CEA,NSE联合检测对肺癌的诊断价值[J].现代检验医学杂志,2019,34(03):99.[doi:10.3969/j.issn.1671-7414.2019.03.024]
　ZHANG Li-xiang,PAN Jing,ZHAO Jie,et al.Value of the Combined Determination of Sputum Liquid-Based Cytologyand Serum CYFRA21-1,CEA,NSE for the Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2019,34(06):99.[doi:10.3969/j.issn.1671-7414.2019.03.024]
[6]孙树凯,田清武,刘入华,等.血清ProGRP,NSE和CEA检测对小细胞肺癌的诊断价值[J].现代检验医学杂志,2016,31(01):77.[doi:10.3969/j.issn.1671-7414.2016.01.022]
　SUN Shu-kai,TIAN Qing-wu,LIU Ru-hua,et al.Value of Serum ProGRP,NSE and CEA Detection in Diagnosis of Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):77.[doi:10.3969/j.issn.1671-7414.2016.01.022]

备注/Memo

备注/Memo:
作者简介:蒋海兵(1982-),男,本科,主管检验技师,研究方向为生化和发光检验,E-mail:287050365@qq.com。
更新日期/Last Update: 2018-11-30